To test the biological effects of TTP in prostate cancer, PC-3 cells were transduced with a reverse tetracycline-inducible (Tet-On) expression system, to allow for inducible TTP expression following the addition of doxycycline (Dox) to the cell culture media. Here, ZFP36 is linked to prostate carcinoma.